Addus HomeCare (ADUS)
(Delayed Data from NSDQ)
$94.54 USD
+2.84 (3.10%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $94.49 -0.05 (-0.05%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth A Momentum A VGM
Price, Consensus and EPS Surprise
ADUS 94.54 +2.84(3.10%)
Will ADUS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ADUS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ADUS
ADUS vs. USPH: Which Stock Is the Better Value Option?
Elevance Health (ELV), CD&R to Unveil Primary Care Offering
ADUS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Medical Stocks Lagging HCA Healthcare (HCA) This Year?
ADUS vs. USPH: Which Stock Should Value Investors Buy Now?
Acadia (ACHC) Buys CTCs to Boost Care Access in North Carolina
Other News for ADUS
Roblox upgraded, Qualcomm initiated: Wall Street's top analyst calls
Cracking The Code: Understanding Analyst Reviews For Addus HomeCare
Roblox upgraded, Qualcomm initiated: Wall Street's top analyst calls
Barclays downgrades Addus to Underweight on 'materially negative' regulation
Addus HomeCare Comments on Final Department of Health and Human Services Rule